The associations between DNA methylation and depression: A systematic review and meta-analysis
Journal of Affective Disorders · 2023-04 · 327 · 439-450
DOI: 10.1016/j.jad.2023.01.079 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Affective Disorders, 2023-04. Verfasst von Jia-Hui Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China; Center for Suicide Pre…. Hauptthemen laut MEDLINE: Depression, DNA Methylation. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Growing evidence suggests that epigenetic modification is vital in biological processes of depression. Findings from studies exploring the associations between DNA methylation and depression have been inconsistent. METHODS: A systematical search of EMBASE, PubMed, Web of Science, and PsycINFO databases was conducted to include studies focusing on the associations between DNA methylation and depression (up to November 1st 2021) according to PRISMA guidelines with registration in PROSPERO (CRD42021288664). RESULTS: A total of 47 studies met inclusion criteria and 31 studies were included in the meta-analysis. This meta-analysis found that genes hypermethylation, including BDNF (OR: 1.15, 95%CI: 1.01-1.32, I2 = 90 %), and NR3C1 (OR: 1.43, 95%CI: 1.09-1.87, I2 = 88 %) was associated with increased risk of depression. Significant association of SLC6A4 hypermethylation with depression was only found in the subgroup of using original data (OR: 1.09, 95%CI: 1.01-1.19, I2 = 52 %). BDNF hypermethylation could increase the risk of depression only in the Asian population (OR: 1.18, 95%CI: 1.01-1.40, I2 = 91 %), and significant associations of NR3C1 hypermethylation with depression were found in the group for depressive symptoms (OR: 1.34, 95%CI: 1.08-1.67, I2 = 85 %), but not for depressive disorder (OR: 1.89, 95%CI: 0.54-6.55, I2 = 94 %). LIMITATIONS: More studies are needed to explore the factors that might influence the estimates owing to the contextual heterogeneity of the pooling of included studies. CONCLUSIONS: It is noted that DNA hypermethylation, namely BDNF and NR3C1, is associated with increased risk of depression. The findings in this study could provide some material evidence for preventing and diagnosing of depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China; Center for Suicide Prevention Research, Shandong University, Jinan, Shandong, China.
- Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China; Center for Suicide Prevention Research, Shandong University, Jinan, Shandong, China. Electro…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhu, J. H., Bo, H. H., Liu, B. P., & Jia, C. X. (2023). The associations between DNA methylation and depression: A systematic review and meta-analysis. Journal of Affective Disorders, 327, 439-450. https://doi.org/10.1016/j.jad.2023.01.079
Vancouver
Zhu JH, Bo HH, Liu BP, Jia CX. The associations between DNA methylation and depression: A systematic review and meta-analysis. Journal of Affective Disorders. 2023;327:439-450. doi:10.1016/j.jad.2023.01.079
BibTeX
@article{Zhu2023,
author = {Zhu, Jia-Hui and Bo, Hao-Hui and Liu, Bao-Peng and Jia, Cun-Xian},
title = {The associations between DNA methylation and depression: A systematic review and meta-analysis},
journal = {Journal of Affective Disorders},
year = {2023},
volume = {327},
pages = {439--450},
doi = {10.1016/j.jad.2023.01.079}
}
EUVIMED